Premium
Iron chelation for myelofibrosis‐related anaemia during treatment with a Janus kinase inhibitor
Author(s) -
Ross David M.
Publication year - 2022
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1111/bjh.18071
Subject(s) - medicine , deferasirox , ruxolitinib , deferiprone , myelofibrosis , chelation therapy , gastroenterology , adverse effect , anemia , myelodysplastic syndromes , ferritin , deferoxamine , thalassemia , bone marrow
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom